The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene/Jazz; Daiichi Sankyo; Eisai; Exact Sciences; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; RIEMSER; Roche; Sandoz; Seagen; tesaro; Teva
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene; Daiichi Sankyo; Eisai; Exact Sciences; GlaxoSmithKline; GlaxoSmithKline; Lilly; Lilly; MSD; MSD; NanoString Technologies; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; RIEMSER; Roche; Sandoz; Seagen; Tesaro; Teva
Speakers' Bureau - Agendia; Amgen; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Carl Zeiss Meditec; Celgene; Daiichi Sankyo; Eisai; Exact Sciences; GlaxoSmithKline; Lilly; MSD; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; RIEMSER; Roche; Sandoz; Seagen; Tesaro; Teva
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene/Jazz; Daiichi Sankyo; Eisai; Exact Sciences; GlaxoSmithKline; Lilly; MSD; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; RIEMSER; Roche; Sandoz; Seagen; Tesaro; Teva
ADAPTlate: A randomized, controlled, open-label, phase III trial on adjuvant dynamic marker—Adjusted personalized therapy comparing abemaciclib combined with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy in (clinical or genomic) high-risk, HR+/HER2- early breast cancer.
 
Oleg Gluz
Honoraria - AstraZeneca; Celgene; Exact Sciences; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Exact Sciences; MSD; Roche
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; Roche
 
Iris Scheffen
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Celgene
 
Tom Degenhardt
Honoraria - Pfizer
Consulting or Advisory Role - Roche/Genentech
Research Funding - pfizer (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Tesaro
 
Norbert Walter Marschner
Employment - iOMEDICO
Leadership - iOMEDICO
Stock and Other Ownership Interests - iOMEDICO
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Research Funding - Lilly
 
Matthias Christgen
No Relationships to Disclose
 
Hans Heinrich Kreipe
Honoraria - Amgen; AstraZeneca; Exact Sciences; Novartis; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Novartis; Pfizer; Pfizer; Roche
 
Ulrike Nitz
Honoraria - Agendia; Amgen; Celgene; Exact Sciences; NanoString Technologies; Novartis; Pfizer; Roche/Genentech; Teva
Consulting or Advisory Role - Exact Sciences; Roche
Research Funding - Agendia; Amgen; Celgene; Exact Sciences; Exact Sciences; NanoString Technologies; Roche; Sanofi
Expert Testimony - Exact Sciences
Travel, Accommodations, Expenses - Exact Sciences
 
Ronald E. Kates
Honoraria - Amgen; Celgene; Exact Sciences; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - Agendia; AstraZeneca; Celgene; Daiichi Sankyo; Lilly; Merck Sharp & Dohme; Novartis; Odonate Therapeutics; Pfizer; Roche; Sandoz; Seagen
 
Timo Schinkoethe
Leadership - CANKADO
Stock and Other Ownership Interests - CANKADO
 
Monika Karla Graeser
No Relationships to Disclose
 
Rachel Wuerstlein
No Relationships to Disclose
 
Sherko Kuemmel
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Genomic Health; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; Roche/Genentech; SOMATEX; Sonoscape
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche; Sonoscape
(OPTIONAL) Uncompensated Relationships - West German Study Group
 
Lelia Bauer
No Relationships to Disclose
 
Christian Schem
No Relationships to Disclose
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Hans Neubauer
No Relationships to Disclose
 
Nadia Harbeck
Stock and Other Ownership Interests - West German Study Group
Honoraria - Amgen; AstraZeneca; Genomic Health; Novartis; Pfizer; Pierre Fabre; Roche; Zodiac Pharma
Consulting or Advisory Role - Agendia; AstraZeneca; Celgene; Daiichi Sankyo; Lilly; Merck Sharp & Dohme; Novartis; Odonate Therapeutics; Pfizer; Pierre Fabre; Roche/Genentech; Sandoz; Seagen; West German Study Group (I)
Research Funding - Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)